menu
    • menu

    Company profile for Rubius Therapeutics

    NEW Drugs in Dev: 5
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Rubius Therapeutics, a 2017 “Fierce 15” award winner, is creating RCTs as an innovative new class of cellular therapies which address a wide array of diseases and disorders. The company’s lead programs include cancer, enzyme replacement therapy and tolerance induction. Rubius was conceived and launched by Flagship VentureLabs , the institutional innovation foundry where a team of scientific entrepreneurs systematically...
    Rubius Therapeutics, a 2017 “Fierce 15” award winner, is creating RCTs as an innovative new class of cellular therapies which address a wide array of diseases and disorders. The company’s lead programs include cancer, enzyme replacement therapy and tolerance induction. Rubius was conceived and launched by Flagship VentureLabs , the institutional innovation foundry where a team of scientific entrepreneurs systematically evolves enterprising ideas into new fields, or previously undiscovered areas of science into real-world inventions and ventures.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rubius TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    325 Vassar Street, Suite 1A, Cambridge, MA 02139,
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rubiustx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/rubius-therapeutics/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    In wake of Rubius downfall, a new biotech spinout launches to 'take the next step' in red blood cell therapies
    In wake of Rubius downfall, a new biotech spinout launches to 'take the next step' in red blood cell therapies

    23 May 2023

    // Amber Tong ENDPTS

    https://endpts.com/university-of-bristol-spinout-scarlet-raises-seed-round-for-therapeutic-red-blood-cells/

    Amber Tong ENDPTS
    23 May 2023
    Share Share
    After Rubius collapse and brief stop at startup, Pablo Cagnoni start at Incyte
    After Rubius collapse and brief stop at startup, Pablo Cagnoni start at Incyte

    08 May 2023

    // Amber Tong ENDPTS

    https://endpts.com/incyte-names-ex-rubius-ceo-pablo-cagnoni-as-president-head-of-rd/

    Amber Tong ENDPTS
    08 May 2023
    Share Share
    After last-ditch effort, Rubius moves to dissolve
    After last-ditch effort, Rubius moves to dissolve

    22 Feb 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/after-last-ditch-effort-cellular-medicine-biotech-rubius-moves-dissolve

    Annalee Armstrong FIERCE BIOTECH
    22 Feb 2023
    Share Share
    Ex-Rubius CEO dusts himself off at a different Flagship biotech
    Ex-Rubius CEO dusts himself off at a different Flagship biotech

    18 Nov 2022

    // Alex Hoffman ENDPTS

    https://endpts.com/ex-rubius-ceo-dusts-himself-off-at-a-different-flagship-biotech-hutchmed-switches-things-up-during-pipeline-refocus/

    Alex Hoffman ENDPTS
    18 Nov 2022
    Share Share
    Former Rubius CEO to lead buzzy Flagship startup
    Former Rubius CEO to lead buzzy Flagship startup

    17 Nov 2022

    // BIOPHARMADIVE

    https://www.biopharmadive.com/news/laronde-ceo-cagnoni-rubius-flagship/636857/

    BIOPHARMADIVE
    17 Nov 2022
    Share Share
    Rubius Announces Process to Explore Strategic Alternatives & Leadership Changes
    Rubius Announces Process to Explore Strategic Alternatives & Leadership Changes

    02 Nov 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/11/02/2546990/0/en/Rubius-Therapeutics-Announces-Process-to-Explore-Strategic-Alternatives-and-Leadership-Changes.html

    GLOBENEWSWIRE
    02 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search